Celltrion

(Image: Getty/Filipfoto)

US FDA eases Teva headache with Ajovy approval

By Flora Southey

Regulatory setbacks at Teva’s CMO facility in Korea have not halted the regulatory progression of preventive migraine treatment Ajovy, which has received US FDA approval.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers